Determinants of Medical System Delay in the Diagnosis of Colorectal Cancer Within the Veteran Affairs Health System
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Background and Aims
The goals of this study are to evaluate determinants of the time in the medical system until a colorectal cancer diagnosis and to explore characteristics associated with stage at diagnosis.
We examined medical records and survey data for 468 patients with colorectal cancer at 15 Veterans Affairs medical centers. Patients were classified as screen-detected, bleeding-detected, or other (resulting from the evaluation of another medical concern). Patients who presented emergently with obstruction or perforation were excluded. We used Cox proportional hazards models to determine predictors of time in the medical system until diagnosis. Logistic regression models were used to determine predictors of stage at diagnosis.
We excluded 21 subjects who presented emergently, leaving 447 subjects; the mean age was 67 years and 98% were male, 66% Caucasian, and 43% stage I or II. Diagnosis was by screening for 39%, bleeding symptoms for 27%, and other for 34%. The median times to diagnosis were 73–91 days and were not significantly different by diagnostic category. In the multivariable model for time to diagnosis, older age, having comorbidities, and Atlantic region were associated with a longer time to diagnosis. In the multivariable model for stage-at-diagnosis, only the diagnostic category was associated with stage; the screen-detected category was associated with decreased risk of late-stage cancer.
Our results point to several factors associated with a longer time from the initial clinical event until diagnosis. This increased time in the health care system did not clearly translate into more advanced disease at diagnosis.
- Cancer Statistics. 2008. http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf.
- Ramos M, Esteva M, Cabeza E, et al. Lack of association between diagnostic and therapeutic delay and stage of colorectal cancer. Eur J Cancer. 2008;44(4):510–521. CrossRef
- Wattacheril J, Kramer JR, Richardson P, et al. Lagtimes in diagnosis and treatment of colorectal cancer: determinants and association with cancer stage and survival. Aliment Pharmacol Ther. 2008;28(9):1166–1174. CrossRef
- Korsgaard M, Pedersen L, Sorensen HT, et al. Reported symptoms, diagnostic delay and stage of colorectal cancer: a population-based study in Denmark. Colorectal Disease. 2006;8(8):688–695. CrossRef
- Ayanian JZ, Chrischilles EA, Fletcher RH, et al. Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. [erratum appears in J Clin Oncol. 2004 Dec 15;22(24):5026]. J Clin Oncol. 2004;22(15):2992–2996.
- Lasson A, Kilander A, Stotzer PO. Diagnostic yield of colonoscopy based on symptoms. Scand J Gastroenterol. 2008;43(3):356–362. CrossRef
- Lieberman DA, de Garmo PL, Fleischer DE, et al. Colonic neoplasia in patients with nonspecific GI symptoms. Gastrointest Endosc. 2000;51(6):647–651. CrossRef
- Pepin C, Ladabaum U. The yield of lower endoscopy in patients with constipation: survey of a university hospital, a public county hospital, and a Veterans Administration medical center. Gastrointest Endosc. 2002;56(3):325–332. CrossRef
- Piccirillo JF, Tierney RM, Costas I, et al. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA. 2004;291(20):2441–2447. CrossRef
- VA Facility Complexity Model. Oncology Program Evaluation, Facilities Survey Report at www.va.gov/cancer/ Report.
- He YZA, Harrington DP. Imputation in a multiformat and multiwave survey of cancer care. In: Proceedings in Health Policy Statistics. American Statistical Association; 2007.
- Hosmer D, Lemeshow S. Applied Logistic Regression. 2nd ed. New York: Wiley; 2000.
- Little R, Rubin DB. Statistical Analysis with Missing Data. New York: Wiley; 1986.
- Singh HDK, Petersen LA, Collins C, et al. Missed opportunities to initiate endoscopic evaluation for colorectal cancer diagnosis. Am J Gastroenterol. 2009 online publication.
- Wennberg JE, Fisher ES, Skinner JS. “Geography and the debate over Medicare reform.” Health Affairs. 2002; W96–114.
- Welch WP, Miller ME, Welch HG, Fisher ES, Wennberg JE. Geographic variation in expenditures for physicians’ services in the United States. N Engl J Med. 1993;328:621–627. CrossRef
- Fisher ES, Wennberg JE, Stukel TA, et al. Associations among hospital capacity, utilization, and mortality of US Medicare beneficiaries, controlling for sociodemographic factors. Health Serv Res. 2000;34:1351–1362.
- Gellad ZF, Almirall D, Provenzale D et al. Time from positive screening fecal occult blood test to colonoscopy and risk of neoplasia. Dig Dis Sci. 2009 in press.
- Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348(9040):1472–1477. CrossRef
- Kronborg O, Fenger C, Olsen J, Jorgensen OD, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348(9040):1467–1471. CrossRef
- Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota colon cancer control study. N Engl J Med. 1993;328(19):1365–1371. CrossRef
- Determinants of Medical System Delay in the Diagnosis of Colorectal Cancer Within the Veteran Affairs Health System
Digestive Diseases and Sciences
Volume 55, Issue 5 , pp 1434-1441
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Colorectal neoplasms
- Industry Sectors
- Author Affiliations
- 1. Health Services Research and Development, Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, 508 Fulton Street (152), Durham, NC, 27705, USA
- 2. Division of Gastroenterology, Department of Medicine, Duke University Medical Center, Durham, NC, USA
- 3. Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA
- 4. Division of Gastroenterology and Hepatology, University of North Carolina, CB# 7555, 4157 Bioinformatics Building, Chapel Hill, NC, 27599-7555, USA
- 5. Professor Emeritus, Department of Population Medicine, Harvard Medical School, 208 Boulder Bluff, Chapel Hill, NC, 27516, USA
- 6. Department of Medicine, Section of Gastroenterology and Hepatology, Michael E DeBakey VA Medical Center & Baylor College of Medicine, Houston, TX, USA